Search Results - "Losy, J."

Refine Results
  1. 1

    PECAM-1, a key player in neuroinflammation by Kalinowska, A., Losy, J.

    Published in European journal of neurology (01-12-2006)
    “…Platelet endothelial cell adhesion molecule‐1 (PECAM‐1, CD31) is a 130‐kDa protein, which plays a significant role in the adhesion cascade. It is therefore…”
    Get full text
    Journal Article
  2. 2

    Early TNF-α levels correlate with ischaemic stroke severity by Zaremba, J., Losy, J.

    Published in Acta neurologica Scandinavica (01-11-2001)
    “…Objectives– The study aimed to evaluate the levels of an important proinflammatory cytokine tumour necrosis factor‐α (TNF‐α) in cerebrospinal fluid (CSF) and…”
    Get full text
    Journal Article
  3. 3
  4. 4

    Monocyte chemoattractant protein-1 is increased in the cerebrospinal fluid of patients with ischemic stroke by LOSY, J, ZAREMBA, J

    Published in Stroke (1970) (01-11-2001)
    “…Animal models of stroke have shown that focal cerebral ischemia results in an increased expression of several cytokines and chemokines that precedes leukocyte…”
    Get full text
    Journal Article
  5. 5
  6. 6
  7. 7

    IL-18 in patients with multiple sclerosis by Losy, J., Niezgoda, A.

    Published in Acta neurologica Scandinavica (01-09-2001)
    “…IL‐18 is a cytokine which plays an important role in Th‐1 response through its ability to induce IFN‐gamma production in T cells and NK cells. The purpose of…”
    Get full text
    Journal Article
  8. 8

    Interleukin-18 in acute ischaemic stroke patients by Zaremba, J, Losy, J

    Published in Neurological sciences (01-10-2003)
    “…As proinflammatory cytokines released during ischaemia are detrimental to the brain, the study aimed to evaluate serum interleukin-18 (IL-18) levels in stroke…”
    Get full text
    Journal Article
  9. 9
  10. 10

    Tumour necrosis factor-alpha is increased in the cerebrospinal fluid and serum of ischaemic stroke patients and correlates with the volume of evolving brain infarct by Zaremba, J, Skrobanski, P, Losy, J

    Published in Biomedicine & pharmacotherapy (01-06-2001)
    “…A growing body of evidence suggests the involvement of inflammatory mediators, including cytokines, in the development of ischaemic brain lesions. The aim of…”
    Get full text
    Journal Article
  11. 11

    sPECAM-1 in serum and CSF of acute ischaemic stroke patients by Zaremba, J., Losy, J.

    Published in Acta neurologica Scandinavica (01-11-2002)
    “…Objectives– As platelet endothelial cell adhesion molecule‐1 (PECAM‐1) is one of key mediators of transendothelial migration of leucocytes during inflammation,…”
    Get full text
    Journal Article
  12. 12
  13. 13
  14. 14

    In vivo effect of interferon-β 1a on interleukin-12 and TGF-β1 cytokines in patients with relapsing-remitting multiple sclerosis by Losy, J., Michałowska-Wender, G.

    Published in Acta neurologica Scandinavica (01-07-2002)
    “…We have studied in vivo effect of interferon‐β 1a (IFN‐β 1a) (6 MIU once weekly i.m.) on interleukin‐12 (IL‐12) and transforming growth factor‐β1 (TGF‐β1)…”
    Get full text
    Journal Article
  15. 15

    The level of chemokine CXCL5 in the cerebrospinal fluid is increased during the first 24 hours of ischaemic stroke and correlates with the size of early brain damage by Zaremba, J, Skrobański, P, Losy, J

    Published in Folia morphologica (01-02-2006)
    “…Inflammation is an important feature of the pathophysiological response to ischaemic stroke. The ischaemic brain-invading leukocytes, neutrophils in…”
    Get full text
    Journal Article
  16. 16

    The levels of TNF-alpha in cerebrospinal fluid and serum do not correlate with the counts of the white blood cells in acute phase of ischaemic stroke by Zaremba, J, Losy, J

    Published in Folia morphologica (2001)
    “…Stroke-induced inflammatory reaction, which leads to invasion of leukocytes into the evolving brain infarct, seems to play a key role in the deterioration of…”
    Get full text
    Journal Article
  17. 17

    Effect of cladribine treatment on beta-2 microglobulin and soluble intercellular adhesion molecule 1 (ICAM-1) in patients with multiple sclerosis by Niezgoda, A, Losy, J, Mehta, P D

    Published in Folia morphologica (01-08-2001)
    “…beta-2 Microglobulin (beta 2M) is a low molecular weight protein located extracellularly and associated with class 1 antigens of the major histocompatibility…”
    Get full text
    Journal Article
  18. 18

    Update paper of the scientist panel on demyelinating diseases: is multiple sclerosis still a diagnostic and therapeutic enigma? by Wender, M., Losy, J.

    Published in European journal of neurology (01-07-1997)
    “…Despite great progress in the diagnosis and therapy of multiple sclerosis (MS) some problems remain unsolved. For example, should immunologically negative…”
    Get full text
    Journal Article
  19. 19
  20. 20

    REVIEW ARTICLE: PECAM-1, a key player in neuroinflammation by Kalinowska, A, Losy, J

    Published in European journal of neurology (01-12-2006)
    “…Platelet endothelial cell adhesion molecule-1 (PECAM-1, CD31) is a 130-kDa protein, which plays a significant role in the adhesion cascade. It is therefore…”
    Get full text
    Journal Article